New Guidelines: ctDNA Testing, Breast Cancer (+++++ +++++)

Oncology ctDNA Testing: Guiding Treatment Selection https://reference.medscape.com/cc2/p10/asco-guideline-ctdna-testing-2026a1000o2h?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 Familial Breast Cancer: Genetic Testing and Surveillance https://reference.medscape.com/cc2/p10/familial-breast-cancer-secondary-care-classification-care-2022a100229s?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 Lymphomas: Relapsed/Refractory Systemic Therapy https://reference.medscape.com/cc2/p10/esmo-guideline-lymphomas-diagnosis-treatment-and-follow-2026a1000jsj?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 AML in Older Adults: Antileukemic Therapies https://reference.medscape.com/cc2/p10/ash-guideline-acute-myeloid-leukemia-older-adults-2026a1000f9u?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 Familial Ovarian Cancer: Risk-Reducing Surgery https://reference.medscape.com/cc2/p10/ovarian-cancer-identifying-and-managing-familial-and-genetic-2024a10004x9?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 Systemic Therapy for Thyroid Cancer: First-Line Systemic Therapies https://reference.medscape.com/cc2/p10/asco-guideline-systemic-therapy-thyroid-cancer-2026a1000p8a?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 Management of Relapsed/Refractory ALL in AYAs: CNS Relapse https://reference.medscape.com/cc2/p10/ash-guideline-relapsed-acute-lymphoblastic-leukemia-2026a1000fnz?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 Muscle-Invasive and Metastatic Bladder Cancer: Managing Platinum-Refractory UC https://reference.medscape.com/cc2/p10/eau-guidelines-muscle-invasive-and-metastatic-bladder-cancer-2024a1000ddk?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 Renal Cell Carcinoma: Patient Follow-Up https://reference.medscape.com/cc2/p10/eau-guideline-renal-cell-carcinoma-2024a1000im7?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334 Multiple Myeloma & MGUS: Dosing for ASCT https://reference.medscape.com/cc2/p10/dkg-awmf-guideline-mgus-multiple-myeloma-2026a1000tli?ecd=WNL_drugguide_260916_MSCPREF_onc_etid8694334&uac=148436CN&impID=8694334